A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...

PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...

In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...

Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.

A model integrating deep learning with clinical and epidemiologic data may significantly improve lung cancer risk prediction based on LDCT screening.

Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.

A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

GRAIL, Inc. GRAL recently announced a strategic collaboration with Epic to integrate its Galleri multi-cancer early detection ...

Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal. Collaboration With Epic Will Allow Clinicians to ...